Raymond James took its Atlantic Capital [ACBI] rating to the equivalent of Outperform from Market Perform, in a research note dated 2021-01-25. Other analysts also revised their coverage, with Raymond James’s analysts downgrading the shares from “an Outperform” rating to “an Mkt perform” rating in a research note to investors issued in late April. Meanwhile, Sandler O’Neill had raised its rating on ACBI to “Buy” from the earlier “Hold”, in a research note produced for clients November 19, 2018. In addition, there was an upgrade from Raymond James on November 16, 2018. The rater changed ACBI from “a Mkt perform” to “an Outperform”.
Is Atlantic Capital Bancshares Inc. [NASDAQ: ACBI] a Good Buy Right Now?
It should be noted that ACBI technical indicators for short, intermediate as well as long term progress have placed an overall average of 100% as Buy. The average signal changed from 100% Buy in the last week and compares with 96% Buy in the past month. Data from Atlantic Capital Bancshares Inc.’s Trend Spotter indicated that the signals were Strongest. The stock current average is 65960.0 shares in the past 20 days and the short term average signal indicates a 100% Buy. In the last 50 days, the average trading volume was 84342.0 shares while the medium-term average advocated for 100% Buy. The average long-term signal stands at 100% Buy and the 100-day average volume stands at 84952.0 shares.
ACBI Price Performance
On Wall Street, Atlantic Capital Bancshares Inc. [NASDAQ:ACBI] finished Friday’s session up 3.06% at $17.52. The stock went up to $17.54 at the same session while its lowest single-day price was $16.725. In the last five days, it saw a fall of about -0.06%, Atlantic Capital Bancshares Inc. shares gained by almost 10.05% since the beginning of the year. However, the share price has dropped to as low as -13.31% below its one year high. On 01/15/21, the company shares recorded $17.68, the highest single-day price it has got to in the last 52-weeks, and a 52-week low was seen on 01/04/21, the same year at $15.49. The company’s shares have declined by -1.74% in the past year. The 50-day SMA achieved is $15.89 while the 200-day SMA is $12.77. Volume gained to 87073.0 from 81100.0 in the previous session.